| 发明名称 | Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine | ||
| 摘要 | A method of treating myocardial infarction in a subject using a water-soluble cocrystal composition which contains a quantity of acetylsalicylic acid and a quantity of a theanine enantiomer. | ||
| 申请公布号 | US9289440(B2) | 申请公布日期 | 2016.03.22 |
| 申请号 | US201414295684 | 申请日期 | 2014.06.04 |
| 申请人 | THEAPRIN PHARMACEUTICALS INC. | 发明人 | Brittain Harry G.;Felice Philip V. |
| 分类号 | A61K31/60;A61K31/12;A61K31/616;A61K31/198;C07C67/52;C07C231/22;A61K9/00;A61K45/06;A61K9/14 | 主分类号 | A61K31/60 |
| 代理机构 | Notaro, Michalos & Zaccaria P.C. | 代理人 | Notaro, Michalos & Zaccaria P.C. |
| 主权项 | 1. A method of treating myocardial infarction in a subject in need thereof by administering to the subject an effective amount of a water-soluble composition comprising: a cocrystal composition containing a quantity of acetylsalicylic acid and a quantity of a theanine enantiomer selected from the group consisting of L-theanine, D-theanine, and DL-theanine. | ||
| 地址 | Hauppauge NY US | ||